Navigation Links
Mass. Eye and Ear Researcher receives RPB Award

Boston (July 20, 2012) The Massachusetts Eye and Ear Infirmary and Harvard Medical school has been granted a $250,000 Research to Prevent Blindness (RPB) Career Development Award to support the work of Mass. Eye and Ear ophthalmologist Dr. Joseph Ciolino.

Dr. Ciolino obtained his medical degree from Georgetown University School of Medicine, and completed an Internal Medicine internship at Brown University and his ophthalmology residency at Albany Medical College, where he served as Chief Resident in his final year. He completed a fellowship in the Cornea, Refractive Surgery and External Disease Service at Mass. Eye and Ear, where he received the nationally recognized Claes Dohlman Fellowship Award. Following his fellowship, Dr. Ciolino joined Harvard Medical School's full time faculty at Mass. Eye and Ear. His clinical focus is in corneal transplants, keratoprosthesis and diseases of the anterior segment of the eye.

Dr. Ciolino's research interests include translational projects such as keratoprosthesis and ocular drug delivery. He has been working with collaborators at Children's Hospital Boston and MIT on developing a drug-eluting contact lens which has been covered by international news services including CNN, Reuters News Service, and Scientific American.

The RPB Career Development Award Fund was established in 1990 to attract young physicians and basic scientists to eye research. To date, the program has recruited 164 vision scientists to research positions in departments of ophthalmology at universities across the country.


Contact: Vannessa Carrington
Massachusetts Eye and Ear Infirmary

Page: 1

Related medicine news :

1. Mass. Eye and Ear and HMS department of ophthalmology receives RPB Grant
2. BUSM researchers identify genetic markers for testosterone, estrogen level regulation
3. UGA researchers develop rapid diagnostic test for pathogens, contaminants
4. Moffitt Cancer Center researchers find potential key to new treatment for mantle cell lymphoma
5. Researchers link Kawasaki Disease in childhood with increased risk of adult heart disease
6. Nursing researcher uses Nintendo Wii to fight cancer-related fatigue
7. Researchers to use novel metabolomics technology for COPD
8. Researchers hit back at early bodycheck theory
9. Cleveland Clinic researchers discover molecule that may prevent atherosclerosis
10. Researchers developing new multiple sclerosis drug that can be taken orally
11. Ordinary chickens may be extraordinary in fighting cancer, says Texas A&M researcher
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... XTC ... selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest ... CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, ...
(Date:12/1/2015)... ... , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won ... order will be from the China Disabled Persons’ Federation, a central government association, for ... for children and adults suffering from severe and profound hearing loss . The ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation ... deploy and support Cisco Unified Contact Center solutions targeted to the high-end enterprise ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... December 1, 2015 --> ... research report "Nucleic Acid Labeling Market by Product (Reagents ... Random Primer, In Vitro Transcription, Reverse Transcription, End Labeling), ... MarketsandMarkets, The global market is expected to reach USD ... 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , Dec. 01, 2015 ... announced the addition of the ... Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, ... report to their offering. --> ... addition of the "2016 Europe ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
Breaking Medicine Technology: